The TEPI Patch technology can be used for many other therapeutic areas and provides an excellent platform for the development of a wide range of drug delivery products. This excludes biologics, but includes drugs such as nicotine that are already delivered through a patch, in addition to others where patch delivery was not previously viable.
Medherant has worked with around 30 candidate drugs to date and, of these, 75-80% are fully soluble. All of those that dissolve are then released again and cross membranes in permeation studies and we can vary their rate of permeation by either changing their concentration or adding excipients to alter how they leave the adhesive and cross the skin. Other drugs that yield dispersions rather than fully dissolving can also still be delivered.
Contact us to discuss your molecule of interest.